Seabridge Gold Inc. (Canada) (NYSE:SA)

Chart of the Day April 13th, 2016

View Entire Video (21:36)
Chart of the Day
April 13th, 2016
   01:33
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
SA Weekly Chart

Old Forum Content for SA

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • scottrades: Some Individual #Gold miners squeezing higher: $NEM $KGC $SA $BTG $GORO $DRD $GOLD
  • DavidM: $SA just will not quit. Nearing 6 year high.
  • kt4000: $SA Im a believer from the Webinar the other day - still moving straight up - slowly but straight up. Looking to add $T for the dividend next week but only on a pullback.
  • SierraJW: ...
    85.46% $SSN Samson Oil & Gas L 1.00 200
    29.15% $JST Jinpan Internation 5.45 3690
    27.69% $EBIO Eleven Biotherapeu 0.50 2000
    27.03% $AFMD Affimed N.V. 4.70 33730
    20.19% $DRWI DragonWave Inc 0.13 300
    17.83% $XGTI xG Technology Inc 0.23 794
    17.06% $ ...
  • steve71: @GreenGhost $GOLD $GDX $NUGT $GLD $SA OptionMonster David Russell has mentioned Seabridge Gold. The chart looks better than most of the gold charts.
  • GreenGhost: @steve71 $GOLD $GDX $NUGT $GLD $SA Could be ; couldn't tell you. I don't want to be messing with specific company operational, financial, regulatory, sovereign and other baggage risks a single entity brings to the table ; my trade purely a levered ( via 3X long ) off the entire sector ( the miners) which is in of itself levered to the underlying commodity ; that trade itself based on the key technical support and resistance levels in the underlying commodity as the record short in institutional position in same
  • steve71: @GreenGhost $GOLD $GDX $NUGT $GLD $SA Point taken. But I prefer the best looking chart. Plus Seabridge is Canadian, avoiding at least the sovereign risk. If gold goes up, we both win. Your $GOLD will win big. If gold does another leg down, well...
  • GreenGhost: @steve71 $GOLD $GDX $NUGT $GLD $SA That's why my trade is my preference VERY clear and well defined levels of risk 1050 below I'M wrong above 1085 in spot trade should do very well ; in the meantime selling weekly OOM Ccs against long $NUGT position as partial hedge . GL with your trade.
  • mradams0621: ...
    $SA Seabridge Gold 7.56 -5.14%
    $X United States Ste... 7.59 -5.12%
    $DWAQ Powershares Excha... 72.77 -4.70%
    $CGG Cgg 3.31 -4.61%
  • Eddy: $SA, anyone else trading this gold ticker? I want a long term position so I sold a close to the money put hoping to get it.
  • Peppermint: My biggest loser lately is $SA. Fortunately I bought some puts last month to hedge my position but still it's been a big loser. Anyone have any thoughts on whether gold stocks are bottoming? Or would you just dump all gold stocks? I am leaning toward holding on theory that bottom is near. Wishful thinking?
  • Aragorn: @Peppermint $SA - into the 3rd std deviation Bollinger - it should snap back but why not use todays low as your out. You already are late to sell. I read Green Ghosts analysis. Keep that in mind, but maybe you can get some of this back. It closed higher than the open that is positive. GL
  • Peppermint: @philharmonic I presume you are talking about $SA, owns big gold fields in Canada. Was holding for long term, but I may start to sell out of this position and keep on watch list for when gold prices bottom. Fortunately, I was hedged with some puts so kept my losses down. I agree I wouldn't add to positions in gold right now. Trying to decide whether to exit or if there is still more downside.
  • Peppermint: @janner0814 Thank you @janner0814. Fortunately I am mostly in uptrending stocks. I have only been with SMM for a few months and still dealing with some old positions. But gradually culling the positions that aren't working. (Re $SA)
  • Peppermint: @GreenGhost Thank you GreenGhost for the great analysis on $GLD. I am thinking I may sell half of my $SA positions and hold the rest. I am still hedged with $6 puts through Aug 21 (Bought as an earnings hedge when it was above $6, didn't expect this big of a drop in $SA.
  • Peppermint: @Aragorn Thanks for your analysis on $SA. I am going to exit half my $SA positions and hold the rest. I have $6 August 21 puts that I bought when $SA was above $6. Have large gains on these. So I am partially hedged on my position. Have 10 $6 puts. Thanks for all the help on the forum.
  • Peppermint: @DAN Dan Thank you for the detail answer re strategies on $GLD and gold stocks. I appreciate your thoughtful answer. Amazing how fast the price of $SA fell, most of the decline the last 3 to 4 trading days. As you and others have pointed out, gold stocks are not working now. So I will begin exiting this position and stay away until such time as the gold sector shows some life. Again I appreciate the great advice from you and others on the forum.
  • bullmoose: Precious Metals - Yesterday I posted that $GLD was catching my eye due to the triple low on the weekly chart. Today I read about George Soros buying a significant amount of $SLW. So I checked some tickers and found the following that really look like good buys here. When you look at them, take a look at their weekly charts first. $SLW and $GG are at the lows of channels and bouncing. But, they're not among my top choices. They are $EGO, $RGLD and $SA, all of which have made higher lows. A COUPLE others to consider are $GOLD AND $BVN. I'm not saying to rush out and buy them. But they are looking tasty.
  • msb: $SA - some of the gold stocks are holding their own in this sell off. I am long SA from last week.
  • msb: $SA - This may be a good entry point for $SA. It has been holding at this support level for over a week. At least it is a low risk entry level. Long.
  • msb: $SA - I posted SA earlier this morning. So far the trade is working.
  • msb: $SA - something lit a fire under $SA today. I don't see any specific news.
  • Tricia: KERX: up 17 % - off a wee bit from high of 17.44 from $SA Keryx longs break out the champagne Shareholders of Keryx Biopharmaceuticals (KERX) want to give Congress a hug after its proposal to delay putting ESRD drugs into to the ACA-mandated payment bundle until 2024 instead of 2016. This bodes well for the company's lead compound, KRX-0502, a treatment for hyperphosphatemia in patients with chronic kidney disease on dialysis. The product's PDUFA date is June 7. Shares are up 18% on a 3x surge in volume in today's trading.
  • :
  • :
  • bocarick: $MNKD - $SA article on $MNKD estimated FDA review 4/1/2014. Many comments on this article, follow back to $SA to read. Long $MNKD stock and call spread
  • Poppy: $V & MA: saw this in $SA around 10-11 am: MasterCard (MA +0.6%) and Visa (V +0.4%) have formed a new payment system group, according to a Bloomberg headline. The companies haven't made any formal announcement yet. Shares of the credit card giants are mildly higher with the scope of the initiative not yet known.
  • Poppy: CBIS: since no one mentioned this ticker - I might as well-from $SA Cannabis Science closes financing Cannabis Science (CBIS) closes its previously announced $1M financing via private placement. The company nets $950,000. Restricted shares were sold at $.25/share plus two-year warrants at $.50/share. I guess we can't get in at that price, can we? just musing...
  • Tricia: OREX: Bought on $VVUS Failure VVUS: Vivus (VVUS) slumps 13.9% to $5.81 despite the company's Q4 earnings beat.However, as $SA author Spencer Osborne points out, $EPS only topped forecasts because of a one-time licensing payment of $34.8M for Vivus' erectile dysfunction drug.Sales of anti-obesity drug Qsymia were $7.7M, in line with estimates at Needham.Qsymia prescriptions +14% on quarter to 124,000.Needham analyst Alan Carr notes that management was disappointed with sales levels, and "outlined plans to improve physician and patient education as well as revenue/prescription in 2014."Qsymia brought in $62.09 per prescription filled in Q4.Net loss narrowed to $17.2M from $56.7M a year earlier.Carr reiterates his Hold rating on Vivus, although BofA cuts its rating to Underperform and sets a price target of $6. BofA cites a looming capital raising and falling expectations about Vivus' ability to sign up a quality partner. Jeffco slashes its $PT to $2 from $5. (PR)
  • chuckd: $GTAT - still interesting article on $SA comparing different qualities of the leading glass products. http://seekingalpha.com/article/2043853-gt-advanced-technology-asf-sapphire-glass-displays-offer-improved-security-longevity-and-confidentiality
  • LouieQuag: CLDX/GILD @Tricia One more thing, you mention that you will monitor the insider selling of $CLDX and I know that you are also quite bullish on $GILD as well. Are you concerned and should we be concerned with the insider selling of GILD. I know that we are awaiting some numbers on the sales of Sovaldi this coming spring and I believe there will be a run up into their earnings so hopefully we don't correct too much from here as we approach their next earnings call. We're a little weak today but I think the entire sector is weak as well. I read this article in $SA and based on the approval of Sovaldi and anticipated success, the size of these insider sales seems strange to me: http://seekingalpha.com/article/2017281-gilead-sciences-5-different-insiders-have-sold-shares-this-year Your responses are always appreciated!
  • Poppy: @bxshin: Thanks for your constant help in the form of daily post like this. I noted that yesterday's post was different, ie. not from $SA - was that right? I get the same 'WallStreet Breakfast'- so the one yesterday was noted. Did #CNBC source dry up too? Just like to compare them all. Hope you are well, nice and warm and not in the winter mess.
  • erdruido: $CHTP - Closed position. Decided not worth the risk waiting for FDA decision tomorrow. Nice balanced article on $SA this morning.
  • jan2138: #yieldhogs: SDRL; I read many of yesterday's posts when I got home and was particularly interested in the link posted to a $SA article which I read with interest. If that article is the reason for the gap down, investors must be really nervous. I can't believe that folks would react based on an obvious amateur's analysis. Remember, $RBC recently rated it "outperform". I added some this morning at 35.50. Since 4th qtr. 2009, they have increased the #dividend 14 times with 2 specials to boot. Is management so insulated that they have lost sight of matching cash flow with #dividend flow? I don't think so.
  • chuckd: $STXS - medical robotics company spiking 13%. small position remaining after harvesting profits. Only news I see is a $SA article interviewing a Doctor who uses their system. Interesting article. quite positive, but can find no other news. hmmm.
  • woodman: $YOD - who here is writing the next $SA article on the next stock? Pleeeeaaase let me know before you do.
  • woodman: $YOD - so, this $SA article sent $YOD up 70% today. This author was red on his investment in $YOD for the entirety of his holding (having bought 1.5 years ago) until today after posting his article on Friday to $SA PRO members and then to the $SA public at large (available for 30 days) this weekend. You can see that it started moving on Friday and took off today. Good way to get into the green. We should all start writing articles for $SA, huh? Seems like a good short this week after the late-comers pile in. http://seekingalpha.com/article/2004371-you-on-demand-the-netflix-of-china?source=yahoo
  • Poppy: ...
    I found more tidbit on $GALE from Sat, $SA that may help propel it some more tomorrow :

    24/7 suggests eight biotech trading near $5 with big upside potential

    24/7's Lee Jackson pinpoints eight small-cap biotech ideas, whose stocks all tra ...
  • bocarick: $DDD $SA article on the end of the bubblehttp://tinyurl.com/lwdndsa by Whitney Tilson
  • Edgarzb: $GTAT @bglee Great find. There is also a $SA article that touches on this same rumor. As far as Corning goes, they are major players. My first reaction would be that it is negative for them, but my first reaction can often be wrong and sometimes companies in the same space in fact move together on positive news. So I guess I would just be guessing. Do you mind if I ask where you found the article in the first place?
  • Tricia: TWITTER : no, not the stock, but the service ... are you on Twitter? do you keep a few windows of Twitter favorites open ... you should really think about doing this if you day or swing trade .... yesterday someone said they could find no news on ...
  • LouieQuag: GTAT@BuffaloBill Just saw this post and decided to some research on GTAT. Found this written for $SA under APPL ticker?Yahoo Finance. Very Interesting: http://seekingalpha.com/article/1968091-apples-solar-powered-iphone-6-and-ipod-touch-under-a-sapphire-hood?source=yahoo And this: http://www.forbes.com/sites/anthonykosner/2014/01/26/apple-to-infinity-mobile-payments-touch-id-and-all-that-sapphire/?partner=yahootix
  • ajitsuthar: $HLF - bought @ below $70.00..as per $SA news: "Not all $MLM are alike," says Citron Research, defending Herbalife. "Citron has NO evidence (their emphasis) that $HLF is operating a pyramid in China."
  • Esslinger: Cardiac Stocks - $ABIO - Arca Biopharma moving up PM, probably on this $SA article yesterday afternoon: http://seekingalpha.com/article/1945191-why-arca-biopharma-is-a-buy
  • jnag698: VEEV- So I looked around and found that Suhail Capital, who wrote that $SA article has written 7 others, all bashing VEEV. If my info is correct, they are based in the Caymans and are a hedge fund. Of course, they could be correct......... or maybe not. $DD is needed by any who desire to play this.
  • bxshin: ...
    Teva names Erez Vigodman as CEO. Teva (TEVA) has appointed board director Erez Vigodman as CEO to replace Jeremy Levin, who resigned in October. Since 2010, Vigodman has been CEO of generic agrochemicals company $MA Industries, where he has led a re ...
  • msb: $GGN @jan2138 - Thanks for the cautionary note - I have seen your post (in the last week or so?) that you are waiting for @Dan to be more positive on gold. I have been stalking the junior miners for some time watching for higher lows. I am long $ANV, $NG, and $SA, all having strong moves today. $NG has broken above the 50 dma and 200 dma. I will probably look to lighten up soon and re-enter if they pull back to support. The long term gold chart still looks like it pull back to test 1000. @Silver on the other hand, has been holding at support for some time. Regards
  • Poppy: $CAT JOY CLF: saw this tonight on $SA ~ 6-7pm U.S. mining equipment makers set to capitalize on Australian mining project Caterpillar (CAT), Joy Global (JOY) and other U.S. mining equipment manufacturers may reap more than $500M in fresh sales after the Export-Import Bank approved nearly $700M in government-backed financing for the A$10B Roy Hill iron ore mining project in Australia. The decision marks a victory for the struggling mining equipment makers, whose sales have plunged during the past year, and a defeat for U.S. miners such as Cliffs Natural Resources (CLF), which had argued the loan would hurt their interests. $CAT CEO @Doug Oberhelman said in October that 75% of the company's projected $11B drop in sales this year will come from the division which primarily sells mining equipment.
  • Jorma: GGRGF - This is a 3-D printing and industrial conglomerate, based in France and currently trading on the European Nyse (under ticker $FINU on the SBF exchange through my broker, IB) and reportedly on the OTC as GGRGF, although my broker cannot find that listing as of yet. It is up 11-12% today, likely on the basis of an $SA article "Why I Believe Groupe Gorge is Worth US 35+ Thanks to its New 3D Printer Business." This looks like a cutting edge company that actually has made significant sales, and also is a conglomerate involved in nuclear infrastructure and waste, underwater robotic mines, mobility and steering of submarines, and all manner of safety systems, etc. I am now long, and looking to get longer. The stock can be followed on StockCharts.com under the ticker GGRGF; caution, it is currently more liquid on the French exchange than OTC market.
  • erdruido: $RXII @fhsavidge @all - Hi, I was wondering if you (or others in the forum) were still following this ticker since your trade back in March (searched the forum, you are now up 2,600%). I was doing some research last night and found few articles on this company in the RNAi field. $SA also has a good informative piece on them. Thank you. Article 1: http://goo.gl/x5Sz8z Article 2: http://goo.gl/igChqm
  • Edgarzb: $NWBO - @Rah I am home today enjoying the snow day so I will probably listen in on it. You may want to check out the $SA article. It has a very in depth look at the fully diluted share count issues and some facts about the companies history. FWIW
  • Poppy: #Yieldhogs: our favorite subject here - from $SA this morning:

    Bells ringing on mortgage #REITs? Goldman says Sell

    Initiating coverage on the sector giants, Goldman sees both Annaly (NLY) and American Capital Agency (AGNC) as Sells.
    " ...
  • darce: $SLCA - blog post on $SA potentially affecting the $SLCA trade, if it gets more attention: http://seekingalpha.com/currents/post/1442521?source=email_rt_mc_readmore. Still long.
  • jetblk: thanx for replying 1boston.I agree $SLCA not at good buy point,stuck in b.band range-for now.I think sand use in well completions will explode more than 20%,read @Michael Filloon at $SA,he knows his stuff and given me many great trade ideas in this sector.I'm trying hard to moderate the fundamentalist in me and "get in touch with my technical side" it's the reason I joined SMM- any help given will be greatly appreciated.
  • darce: $PXD - Wells Fargo comments on Permian operators, including $CXO, $LPI, $ATHL, $FANG, AREX... Blog post at $SA http://seekingalpha.com/currents/post/1438451?source=email_rt_mc_readmore
  • mike12: AMBA-bullish $SA piece http://seekingalpha.com/article/1851001-ambarella-benefits-from-reliable-revenue-growing-opportunities
  • jan2138: SDR @MartySS: your article refers to SDT, not SDR. I did a search on $SA and found the same author's article on SDR. Check it out. He sort of agrees with me that SDR is oversold. Valuation in the 12's.
  • Tricia: 3 DPrinting @otnancy: I was looking for an etf but could not find one ... it appears there may be a reversal beginning ... OR it could be fake. The $SA article was written by admitted shorter and was NOT factual..... not telling anyone to buy ... ...
  • darce: $GOGO - I only got a foot in the door on this one, so just watching...still more buyer than seller. Who doesn't love wireless on airplanes? Could be another momo stock. Comments on $GOGO from $SA http://seekingalpha.com/currents/post/1415762?source=email_rt_mc_readmore&app=1.
  • darce: R2000 @bbt - $TNA my 6th best trade in 2013 so far. Long in trading account. Support is @ 6% below current price. Edit: said differently, the place to buy is 6% below current price. Edit: Blog on small caps at $SA http://seekingalpha.com/currents/post/1416422?source=email_rt_mc_readmore&app=1.
  • darce: $FSLR Solar - blog on $FSLR at $SA http://seekingalpha.com/currents/post/1416502?source=email_rt_mc_readmore&app=1. "First Solar strikes Japanese reseller deal, investing $100M in country..."
  • ginny: ...
    Criteo $SA CRTO 10% $34.00 $31.00 30-Oct-13
    Plains GP Holdings LP PAGP 5% $23.09 $22.00 16-Oct-13
    Brixmor Property Group Inc. $BRX 2% $20.39 $20.00 30-Oct-13
    Global Defense & National Security $GDEF 1% $10.05 $10.00 24-Oct-13
    CommScope Holdi ...
  • darce: $NKE UA - short blog on these two at $SA http://seekingalpha.com/currents/post/1405992?source=email_rt_mc_readmore&app=1. Currently out of the $NKE trade after the blowout earnings. Long UA. $NKE price is actually above the blowout price after earnings, and it looks like it is consolidating nicely.
  • darce: $SLCA - article on $SLCA from $SA http://seekingalpha.com/article/1827892-strengthen-your-portfolio-with-u-s-silica-potential-double-in-12-18-months?source=email_rt_article_readmore&app=1.
  • ginny: ...
    Criteo $SA CRTO 26% $38.99 $31.00 30-Oct-13
    OCI Partners LP OCIP 23% $22.15 $18.00 4-Oct-13
    Springleaf Holdings Inc. $LEAF 19% $20.30 $17.00 16-Oct-13
    Surgical Care Affiliates Inc. $SCAI 13% $27.22 $24.00 30-Oct-13
    Western Refining Logistics ...
  • tnt: $SRPT thanks @woodman and @slowtime, yes I saw the $SA article, seems like an opportunity to get in. $RNA now eliminated as a competitor, so gives $SRPT space and time to do it right
  • Esslinger: $ACAD - @darce, others, please take time to review @Tricia's and @woodman's comments on the $SA article and in general last night on ACAD. The article is also there in my post earlier. I too was concerned the author may have been 'enthusiastic' in his analysis on it's potential value. However, that's not to say one cannot make $$, just be careful.
  • Esslinger: $VISN - Vision China is anyone familiar? Up almost 150% in 2 days! It showed up on my radar today, but looks very suspicious. The following $SA article dated 10/14 as well as the 2nd article (no date) from a sight that leads me to think this dramatic runnup is a possible pump and dump to pay its debts. Very questionable at least...If others know more about this please enlighten. Can it go further? Is this a great short position? Thanks http://seekingalpha.com/article/1744262-visionchina-media-no-fundamental-reason-for-this-rally?source=google_news http://savevisionchina.com Another fairly comprehensive $SA article written today, saying $STAY AWAY essentially, stock's value about $1 maybe. http://seekingalpha.com/article/1745032-the-markets-myopic-view-of-visionchina-media?source=google_news So after all this, IMHO VISN is not worth your time unless you possibly want to short.
  • Esslinger: $ACAD - up 9% today on a $SA article by @Brian Nichols and pimavanserin for it's treatment in Parkinson's disease psychosis (PDP). He also includes in his projections model global estimates off-label and future indications for Alzheimer disease pychosis (ADP) and schizophrenia, and states "the FDA decided that the efficacy was so well proven that they waived the 1.5 to 2 years it would have taken for the final Phase 3 confirmatory trial." Is this an orphan drug designation? Is this guy credible? I know members of this forum have discussed this recently, but saw no mention today. http://seekingalpha.com/article/1743612-pimavanserin-the-most-underestimated-blockbuster-in-biotechnology
  • Poppy: Gov't shut down: If someone has already posted this small piece of news I missed it. So in case there are other like me, here goes: From $SA Friday Wall Street Breakfast column: Firms may have to delay device launches due to shutdown. The government closure could cause device makers such as Google (GOOG) and Apple (AAPL) to postpone the introduction of new smartphones and any other products that emit radio waves. With 98% of FCC staff furloughed, there's no-one around to give the final approval that says the devices don't cause interference. With output at zero, Commissioner Jessica Rosenworcel says the closure "could be something that's a real drag on the digital economy the longer it goes on." Hmm..
  • Tricia: ATRS: follow Scotty at your own risk however ... this time he may be right .... Dr. @Woodman will call him Antares rallies ahead of Otrexup PDUFA date Antares Pharma (ATRS +5.7%) trades markedly higher early on.Possibly helping to tip sentiment is $SA contributor Stock Matusow who reminds investors that $ATRS has a PDUFA date coming up on October 14 for Otrexup.Matusow believes "the FDA approval likelihood ... is over 90%," and says "ATRS should be valued [at or above] $6/share."
  • Tricia: $GALE Galena Biopharma jumps amid Abstral, NeuVax anticipation $CO is enjoying a strong session. Possibly helping the cause are several generally bullish articles published over the weekend by $SA contributors Stock Whisper, @Dutch Trader, and Fusion Research. While optimism surrounding Abstral and NeuVax is running high, investors weren't pleased with the company's recent offering.
  • 5920investsmart: $T - AT&T declares $0.45/share #dividend, in line with prevoius. Forward yield 5.32%. Payable Nov 1, for shareholders of record Oct 10, ex-div Oct 8. $SA
  • rah: $CRM - Hi to all - still busy, but dropped in to have you peek at $CRM - as a follow up to discussions several months ago on stock splits. Even on not so clear cut choices, this one seems to have got on track after a ruff patch. Still think it is a great company, despite assessments in $SA etc.. Not the best buy point now... but an easy hold for now. rah
  • Aragorn: ...
    I know what you are thinking - ok how do I find the SRPT's of the world or the ACAD's and so forth - well you set up scans on software - use Finviz heat maps that I posted every morning for a year I hope people look to finviz because it is a great p ...
  • Tricia: ...
    Shares of Organovo (ONVO) rise in early trading.In a two sentence filing, the company says it has entered into an agreement with Hoffmann La Roche (RHHBY.OB) "exploring the use of 3D liver tissue in toxicology." (8-K)Terms were not disclosed.On Tues ...
  • Tricia: $CYCC - recent opened a very small position ... $CYCC Sapacitabine active against ovarian cancer, Cyclacel soars Cyclacel Pharmaceuticals (CYCC) soars 35% before the bell.A poster presentation from AACR shows the active metabolite of sapacitabine was active against three quarters of isolated primary ovarian cancer samples.By contrast, the chemotherapy drug cisplatin was active in "less than half" of the samples.More than half of the platinum-resistant samples were sensitive to sapacitabine. (PR)Janney initiated the shares at Buy earlier this month.For more, see a recent article by $SA contributor Scrying Biotech who said on September 7 that "with or without you, Cyclacel is going to r
  • Tricia: ...
    Co announces the first patient implant in the Co's US pivotal trial, COUNTER HF. The COUNTER HF study is a prospective, randomized, multi-center, controlled trial that will evaluate the safety and efficacy of the C-Pulse system for the treatment of ...
  • mike12: $AMBA -Needham reiterates as buy, increases $PT from $20 to 21, strong demand in auto cameras, offsetting decreased demand for sports camera. $SA author Assbagi should be thrown in jail for BS short thesis article last week. Can only imagine the amount of puts he had on.
  • Poppy: AMBA- I was lucky to have forgotten that earnings came out last night, to my pleasant surprise. I like the business they have and was aiming for longer term. A blind squirrel and all that jazz. Here is the transcript of CC from $SA site: http://seekingalpha.com/article/1677052-ambarellas-ceo-discusses-f2q-2014-results-earnings-call-transcript?source=email_transcripts&ifp=0 Good luck to us.
  • Poppy: $BV for those holding or betting on this stock...I saw on $SA that the earnings are to be reported today after market hours. GL - no position
  • Iceman: $CYS leads mREITs higher after insider buy - $CYS Investments (CYS +7.1%) leads the mortgage #REITs (REM +2.5%) higher a day after its CEO @Kevin Grant purchased 34K+ shares of company stock. Grant last purchased shares during the month of May (at far higher prices).It's been a busy season of insider buys at the beaten-down mREITs. Of note are a number of purchases at Annaly (NLY +3.2%).Among other movers today: American Capital (AGNC +4.1%), (MTGE +2.7%), Invesco (IVR +3.6%), New York Mortgage (NYMT +2.5%), Anworth (ANH +1.8%), Capstead (CMO +2.4%) (see new $SA contributor MobilePreacher's take: Capstead, The 'Perfect' Security).Related ETFs: (MORT +0.2%), (MORL +5%).
  • woodman: $GALE - Another pump piece today, this time from Motley Fool.http://www.fool.com/investing/general/20... It's not anything enlightening and doesn't say anything that hasn't been written a number of times already. Just like all the pump pieces over at $SA, but hey it sure isn't hurting the price action. I added to mine on the move through $2.26 today.
  • Iceman: $MACK - Paper on Merrimack's Phase II trial of MM-398 drug published - The British Journal of Cancer has published a paper about the Phase II trial of Merrimack Pharmaceuticals' (MACK +5.2%) MM-398 drug for treating late-stage pancreatic cancer. The study met its primary endpoint, with 75% of patients surviving at least 3 months, including 25% who reached the one-year mark. The median overall survival was 5.2 months, while 50% of patients showed evidence of disease control. MM-398 is now in Phase $III trials. (PR) Last week, $SA author Ross Breckendridge noted that Merrimack's share price has been swinging significantly recently in response to interim clinical trial data from MM-121. Breckendridge believes that any downside "has been due to the misconception of the meaning of the data released, and a somewhat poor communication effort by the company."
  • Tricia: NWBO: @Edgarzb - re the $SA article - I specified reading the 40 comments since the article itself is incorrect. I appreciate that you use company information... Like all company PR, it is subject to interpretation. I hope they find a cure. I have no position and will not pursue one. GLTA.
  • Poppy: Biotech Stocks reading: I found this article/interview of an analyst in $SA useful in that it covers a bunch of my holdings...Please use your own judgement as to the validity of the article...since it will be your fingers that will push the buy/sell button. Good luck to us. http://seekingalpha.com/article/1600852-6-oncology-focused-biotech-growth-engines-mara-goldstein?source=email_portfolio&ifp=0
  • JamesL8565: $F --- $SA is reporting that Ford will start selling F150 trucks powered by @CNG. Very little else in the report yet but I would anticipate more information as the stroy develops. Like, for instance, who is going to manufacture the engines? Any thoughts on what this may mean for $WPRT and CMI?
  • DrScience: ...
    His stance was made clear following a decision by France's highest court to examine a challenge to the current law which bans the controversial practice of hydraulic fracturing ("fracking") for extracting shale gas. Fracking was banned in France in ...
  • GregCra: $ALSK @Poppy Apparently the FCC approval of the merger of the wireless assets of General Communications and ALSK. There is an article in $SA saying more: http://seekingalpha.com/article/1555612-fcc-approval-of-merger-of-wireless-assets-is-a-game-changer-for-alaska-communications
  • Tricia: ...
    Celgene has a deep pipeline with progress in Myeloma, MDS, Acute Myeloid Luekemia, Lymphoma, Anemia, and Inflammation. As of Jan there was hope for 3 blockbusters - Apremilist is a disappointment, but Rivelimid and Abraxane for pancreatic cancer ...
  • Drsatx: @Jeff - That is a nice course; allegedly, $SA is supposed to have @rain the next couple of days. Hope that (1) it actually happens, and (2) @rain won't get in the way of your outdoor work.
  • redamber: $SRPT - There is a new article on $SA
  • redamber: $LINE - (IMHO) I believe this to be short covering only; today is ex-div date - the shorts must be out by $EOD or pay dividends. There were 2 bear articles on $SA over the weekend so I fully expect the bear raid to be sustained. Hedgeye is still tweeting about $LINE this morning. I am buying puts near close.
  • couchturnip: $TROV - Above normal volume for the last few days and moving up. New research agreement with $ILMN which according to the article has a history of growth through acquisition. Long at $6.70 from a while back and interested in any ideas/comments on how to buy more and manage the risk. My take: I want to see if it levels out above this new 52 week high, or goes parabolic. This move could all be about the $ILMN agreement and just be short term, or it could be something else. I'd like to see it rest around these levels and establish a price base where I could set a stop in case I'm wrong. In the mean time I'll just enjoy the small piece that I have. Here's the link to the article I found at $SA when looking up $TROV on Yahoo Finance - http://tinyurl.com/o38fz2a
  • rah: $X - also $TS (Tenaris $SA - Basic Mtls. / Steel & Iron) up 9% in the last hour of trade !! Looking into this now. $TS is a 26.44 $B = Mkt cap co. $X is only = 2.78B mkt cap. $TS has 1/2 the revenue. Saw it pop on one of my watchlists, not sure if @Dan covered this one, I think it came from a proprietary site. Have not found any news today. Recently came across their project with Shell Oil and another one with Petrobras the month before. Deep water pipes seem to be their specialty. Let me know if you find anything. - rah
  • Tricia: $PCYC - Pharmacyclics - (-.3.8%) , says results of a Phase II study of ibrutinib in Waldenstrom's Macroglobulinemia patients suggest the drug is a "highly active and well-tolerated treatment" and "provides further evidence" of the role Bruton's tyr ...
  • woodman: $TMUS - that's a good question. I'd have to scour my hard-copy articles. You can't access two of them -- the latter two articles - unless you have $SA Pro. Luckily, I printed them out when they first became available on regular SA. My hazy recollection is that he had written about what $PCS was worth in terms of the buyout, but not what would happen when ultimately bought out and merged with T-Mobile. The buyout was complicated in that I got some shares and some cash, and obviously he couldn't have foreseen how that would work out when he wrote, so it's hard to compare apples to apples at this point.
  • 5920investsmart: $AGNC #Yieldhogs - Just on $SA AGNC book value "10:34 AM American Capital Agency (AGNC -0.2%) estimates book value as of June 7 of $26.44, off 8.6% from $28.93 on March 31. At the current price, the stock is trading at about a 7% discount to book. The numbers were disclosed in slides prepared for the company's presentation at the @Morgan Stanley conference at 3:35 ET this afternoon. Comment! [#Financials]" PDF with $MS slides http://tinyurl.com/k2fopdt
  • bocarick: $MNKD another $SA article putting price target at $27-$28 seekingalpha.com/article/1496482 (sorry tinyurl not working?)
  • rah: Fundimentals @mradams0621 - What a great question. Understanding that the fundamentals are in fact a key component to successful trading for some (so they say); especially (if I can hypothesize) as "time in the trade" increases. For example: a day tr ...
Visit the Trading Forum to join in the discussion.
Stock Price $15.09
Change -0.02%
Volume 410,612

Seabridge Gold, Inc. is a development stage company. It acquires and explores gold properties located in North America.

Request Video of SA
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!